Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 0.0172 | 0.3017 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0233 | 0.057 | 0.1609 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.0172 | 0.3017 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0086 | 0.0127 | 0.2219 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0233 | 0.057 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0233 | 0.057 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0233 | 0.057 | 0.057 |
Plasmodium vivax | phosphatidylinositol 4-kinase, putative | 0.0045 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.0308 | 0.5399 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0131 | 0.0262 | 0.4601 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0233 | 0.057 | 0.1609 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0233 | 0.057 | 1 |
Onchocerca volvulus | 0.0045 | 0 | 0.5 | |
Entamoeba histolytica | hypothetical protein | 0.0131 | 0.0262 | 0.4601 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0131 | 0.0262 | 0.4601 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0131 | 0.0262 | 0.4601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Plasmodium falciparum | phosphatidylinositol 3- and 4-kinase, putative | 0.0045 | 0 | 0.5 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0233 | 0.057 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0045 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Onchocerca volvulus | 0.0045 | 0 | 0.5 | |
Toxoplasma gondii | FATC domain-containing protein | 0.0131 | 0.0262 | 0.4601 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0131 | 0.0262 | 0.0262 |
Plasmodium falciparum | phosphatidylinositol 3-kinase | 0.0045 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Plasmodium falciparum | phosphatidylinositol 4-kinase | 0.0045 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0233 | 0.057 | 0.1673 |
Schistosoma mansoni | hypothetical protein | 0.0101 | 0.0172 | 0.3017 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0146 | 0.0308 | 0.5399 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0233 | 0.057 | 0.057 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0086 | 0.0127 | 0.2219 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0233 | 0.057 | 0.1673 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0146 | 0.0308 | 0.5399 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0131 | 0.0262 | 0.4601 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0233 | 0.057 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0233 | 0.057 | 0.1673 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0233 | 0.057 | 1 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0131 | 0.0262 | 0.4601 |
Leishmania major | hypothetical protein, conserved | 0.1213 | 0.3545 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0233 | 0.057 | 0.1609 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0101 | 0.0172 | 0.0172 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0146 | 0.0308 | 0.5399 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.0262 | 0.4601 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.3341 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1168 | 0.3409 | 1 |
Giardia lamblia | GTOR | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Plasmodium vivax | phosphatidylinositol 3-kinase, putative | 0.0045 | 0 | 0.5 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0233 | 0.057 | 0.1673 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0086 | 0.0127 | 0.0371 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Plasmodium vivax | phosphatidylinositol 4-kinase, putative | 0.0045 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0131 | 0.0262 | 0.077 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0045 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.0127 | 0.2219 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0233 | 0.057 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0233 | 0.057 | 0.057 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0131 | 0.0262 | 0.077 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0146 | 0.0308 | 0.5399 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0101 | 0.0172 | 0.0172 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0131 | 0.0262 | 0.4601 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0233 | 0.057 | 1 |
Echinococcus granulosus | serine protein kinase ATM | 0.0131 | 0.0262 | 0.0262 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0233 | 0.057 | 0.1609 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0131 | 0.0262 | 0.4601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0131 | 0.0262 | 0.4601 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0233 | 0.057 | 0.057 |
Plasmodium vivax | phosphatidylinositol 3- and 4-kinase, putative | 0.0045 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0233 | 0.057 | 0.1673 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Plasmodium vivax | hypothetical protein | 0.0045 | 0 | 0.5 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0131 | 0.0262 | 0.0262 |
Brugia malayi | FAT domain containing protein | 0.0101 | 0.0172 | 0.3017 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0233 | 0.057 | 0.1609 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0233 | 0.057 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0045 | 0 | 0.5 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0131 | 0.0262 | 0.0262 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ln MIC (functional) | = 0 | Antibacterial activity against Enterobacter cloacae OMNFI 174 (Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Acinetobacter calcoloaceticus OSMPV 113 (Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Providencia stuartii CNUR 5(Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Shigella enteritidis (Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Pseudomonas aeruginosa ATCC 9027(Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Staphylococcus aureus MPR 5 (Gram positive) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Staphylococcus aureus ATCC 6538 (Gram positive) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Staphylococcus epidermidis HCF Berset C (Gram positive) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Staphylococcus epidermidis CPHL A2 (Gram positive) strain, activity is expressed as log2MIC. | ChEMBL. | 9171879 |
ln MIC (functional) | = 0 | Antibacterial activity against Streptococcus faecalis LEP Br (Gram positive) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 2 | Antibacterial activity against Klebsiella pneumoniae ATCC 10031 (Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 3 | Antibacterial activity against Escherichia coli ATCC 8739(Gram negative) strain. | ChEMBL. | 9171879 |
ln MIC (functional) | = 3 | Antibacterial activity against Escherichia coli ISF 432(Gram negative) strain. | ChEMBL. | 9171879 |
Log2 MIC (functional) | = 3 | Antibacterial activity against Escherichia coli ATCC 8739(Gram negative) strain. | ChEMBL. | 9171879 |
Log2 MIC (functional) | = 3 | Antibacterial activity against Escherichia coli ISF 432(Gram negative) strain. | ChEMBL. | 9171879 |
MIC (functional) | = 16 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria E. coli ATCC 8739 cell lines | ChEMBL. | 7699714 |
MIC (functional) | = 16 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria E. coli ISF 432 strain. | ChEMBL. | 7699714 |
MIC (functional) | = 16 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria E. coli ATCC 8739 cell lines | ChEMBL. | 7699714 |
MIC (functional) | = 16 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria E. coli ISF 432 strain. | ChEMBL. | 7699714 |
MIC (functional) | = 32 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria Klebsiella pneumoniae ATCC 10031 strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria Enterobacter cloacae OMNFI 174 strain. | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria Acinetobacter calcoaceticus OSMPV 113 strain. | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria Providencia stuartii CNUR 5 strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria Shigella enteritidis | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram negative bacteria Pseudomonas aeruginosa ATCC 9027 strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus aureus MPR 5 strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus aureus ATCC 6538 strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus epidermidis HCF berset C strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram positive bacteria Staphylococcus epidermidis CPHL A2 strain | ChEMBL. | 7699714 |
MIC (functional) | = 128 ug ml-1 | Tested in vitro for inhibitory activity against gram positive bacteria Streptococcus faecalis LEP Br strain | ChEMBL. | 7699714 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.